Conference Details

2009 Best Practices in Primary Care 4/24/2009 - 4/25/2009

Sheraton Philadelphia City Center Hotel
17th & Race Street
Philadelphia , PA 19103
Phone: 215-448-2000

Who Should Attend

All primary care clinicians (physicians, physician assistants, and nurse practitioners) who are active in patient care.

Agenda

4/24/2009 6:30 am - 7:30 am Registration and Complimentary Continental Breakfast 7:30 am - 12:10 pm Morning Sessions 12:10 pm - 12:55 pm Complimentary Lunch 12:55 pm - 3:50 pm Afternoon Sessions 4/25/2009 6:30 am - 7:30 am Registration and Complimentary Continental Breakfast 7:30 am - 12:10 pm Morning Sessions 12:10 pm - 12:55 pm Complimentary Lunch 12:55 pm - 3:50 pm Afternoon Sessions

Venue Information

Meeting Room: Liberty Ballroom C & D

Day rates: Self parking is $25; Valet parking is $44. Overnight rates: Self parking is $38; Valet parking is $44. Gateway Garage (16th and Race) across from hotel does offer lower rates.


Hotel Accommodations:
With so many things to do and see, you might consider bringing your family and turning this conference trip into a vacation at the Sheraton Philadelphia City Center Hotel. Please call 215-448-2000 and mention that you are with the Primary Care Education conference and be sure to call no later than March 24, 2009, to guarantee your room rate of $249 for single/double occupancy per night. Rooms are limited!

Accreditation

ACCME
Primary Care Network, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Primary Care Network designates this educational activity for a maximum of 12.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AAFP
This activity has been reviewed and is acceptable for up to 12.5 Prescribed credits by the American Academy of Family Physicians.

AANP
This program has been approved for 12.5 contact hours of continuing education (which includes 5.7 hours of pharmacology) by the American Academy of Nurse Practitioners. Program ID 0903137. This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.

AAPA
AAPA accepts certificates of participation for educational activities certified for Category I credit from AOACCME, Prescribed credit from AAFP, and AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 12.5 hours of Category I credit for completing this program.

Topics

Menopause   Dialogues in Menopause Management: Facilitating Patient Counseling about Hormone Therapy Overview Healthcare providers and patients alike receive confusing, and even seemingly conflicting, data about the benefit-risk ratio associated with menopausal hormone therapy (HT). In this program, the faculty will present risk concepts in general as well as the most current evidence regarding HT risks and benefits - and how to clearly explain this evidence to their diverse patient population for which HT is considered. The goal of the program is to avoid misperception about HT risk - and, therefore, faulty decision making. Objectives Define absolute risk, relative risk, and clinically significant risk of adverse events and exposure history in meaningful terms as it relates to hormone therapy Identify clinical guidelines and evidence-based approaches for counseling a diverse patient population on the potential benefits and risks of hormone therapy Faculty Bruce Ettinger, MD Emeritus Clinical Professor Medicine University of California, San Francisco San Francisco, CA Adjunct Investigator Division of Research Kaiser Permanente Medical Care Program Oakland, CA Cynthia A. Stuenkel, MD Clinical Professor of Medicine University of California, San Diego La Jolla, CA   Rhinitis   Diagnostic Work-up and Management of Histamine-induced Disorders: Allergic Rhinitis and Chronic Urticaria Overview Allergic rhinitis and chronic idiopathic urticaria, chronic histamine-induced conditions, negatively and significantly impact patient health and quality of life. However, current treatment options are only modestly successful, and obstacles remain to improving outcomes. Diagnostic Work-up and Management of Histamine-induced Disorders: Allergic Rhinitis and Chronic Urticaria will provide primary care clinicians with practical, evidence-based solutions for managing the challenges of these conditions, with an emphasis on finding effective treatments, managing side effects, and ensuring patient compliance. Objectives Identify strategies to overcome barriers for adequate control of allergic rhinitis symptoms Create treatment strategies to improve outcomes for patients with chronic idiopathic urticaria Faculty Myron Zitt, MD Clinical Associate Professor of Medicine Division of Allergy and Immunology State University of New York at Stony Brook Stony Brook, NY Director, Adult Allergy Clinic Division of Allergy and Immunology Nassau University Medical Center East Meadow, NY Sandra Gawchik, DO Co-Director, Division of Allergy and Immunology Asthma and Allergy Associate Clinical Associate Professor of Pediatrics Crozek Chester Medical Center Philadelphia, PA   Atherothrombosis   Prevent The Event: Defining The Role of Oral Antiplatelet Therapy in Atherothrombosis Overview Atherothrombosis is the leading cause of death worldwide and the underlying process in the etiology of acute coronary syndrome (ACS), stroke and vascular death. Cardiovascular risk factors such as obesity, the metabolic syndrome, diabetes mellitus, hypertension, smoking and other "lifestyle" risks contribute to this pandemic of atherothrombotic disease. Patients with ACS, stroke/TIA and PAD (peripheral arterial disease), present major challenges to the primary care clinician in terms of managing CV risk factors and prevention of a second event. This lecture will overview current studies and treatment guidelines for PAD, ACS and Stroke and explore the role of primary care in long-term treatment of these patients. Objectives Describe 3 clinical conditions in which dual antiplatelet therapy is recommended Name 5 treatment recommendations for reduction of global CV risk Faculty Randall M. Zusman, MD, FACC Associate Professor of Medicine Harvard Medical School Director, Division of Hypertension and Vascular Medicine Massachusetts General Hospital Boston, MA David S. Kountz, MD, FACP Associate Professor of Medicine Robert Wood Johnson Medical School New Brunswick, NJ   Dyslipidemia   Early and Aggressive LDL-C Management: Perspectives on Commonly Asked Questions Overview This presentation will address early and aggressive LDL-C management and the clinical challenges of goal attainment. Clinicians will be provided with pathways and knowledge to help them improve their patient outcomes by goal attainment of the healthy lipid profile. Discussion will be applicable to clinicians' practice including lifestyle changes of diet and exercise, along with pharmacologic treatment options available for lipid management in order to give the appropriate tools to get patients to their true LDL goals. Objectives Understand the key tenets of assessing and managing dyslipidemia in clinical practice and the current evidence regarding the safety and efficacy of available LDL-C lowering therapies Identify at least 2 lipid lowering strategies to initiate and tailor comprehensive management treatment plans for patients with high LDL-C in order to reach and maintain targeted goals Faculty Muredach P. Reilly, MB University of Pennsylvania Medical Center Cardiovascular Medicine Division Philadelphia, PA Robert Schainfeld, DO Associate Director, Vascular Medicine Massachusetts General Hospital Boston, MA   Gout   Hyperuricemia and Gout: An Overview of Practice Management and Emerging Therapies Overview Is hyperuricemia another door to the metabolic syndrome? This activity will focus on hyperuricemia and gout and will examine the latest guidance around treating patients in the primary care practice. The program will include a focus on the latest guidelines as well as applying the learning into everyday practice dynamics. Objectives List the key components of a differential diagnosis for gout based on clinical history and physical examination elements Develop a treatment plan, which includes behavioral modification and pharmacologic strategies Faculty N. Lawrence Edwards, MD, FACP, FACR Professor of Medicine Division of Rheumatology and Clinical Immunology Program Director and Vice Chairman Department of Medicine University of Florida Gainesville, FL Paul P. Doghramji, MD, FAAFP Family Physician Collegeville Family Practice Medical Director of Health Services, Ursinus College Collegeville, PA   Smoking Cessation   Do Ask, Do Tell: Successful Smoking Interventions Overview Smoking is the single most important preventable cause of death in the United States. This session, "Do Ask, Do Tell: Successful Smoking Interventions", will address practical ways primary care clinicians can help their patients quit smoking. Objectives Screen all patients for smoking status and design individualized cessation interventions for patients who smoke Commit to active follow-up with patients along the smoking cessation path Faculty Katherine Galluzzi, DO, CMD   Insomnia   Managing Insomnia in Primary Care: Understanding Current and Developing Pharmacological and Nonpharmacological Therapies Overview Insomnia, defined as complaints of disturbed sleep in the presence of adequate opportunity and circumstance for sleep, is the most common adult sleep pathology. Besides cognition, other pathologic processes have been deleteriously associated with insomnia, including cardiovascular morbidity and glycemic control. The latest evidence about sleep pathology will be presented, including spectral analysis that indicates sleep patterns, including slow wave sleep, are important, rather than just total sleep time. Nonpharmacologic approaches, as well as current and developing pharmacotherapies used to address these sleep pathologies will be described. Objectives Identify the underlying causes and comorbid conditions of insomnia for increased confidence in treatment Assess the current and developing nonpharmacologic and pharmacologic approaches to the management of primary and comorbid insomnia Faculty David Neubauer, MD Associate Professor Department of Psychiatry Johns Hopkins University School of Medicine Associate Director Johns Hopkins Sleep Disorders Center Baltimore, MD Paul P. Doghramji, MD, FAAFP Family Physician Collegeville Family Practice Medical Director of Health Services, Ursinus College Collegeville, PA   Osteoporosis   Practical Approaches to the Management of Osteoporosis Overview This program will underscore the importance of osteoporosis screening, risk-benefit analysis, treatment selection, and long-term patient adherence. Evidence-based data on available and emerging pharmacotherapies will be presented to assist with treatment initiation, efficacy issues, and long-term safety assessment. Clinical challenges such as use and interpretation of BMD testing, patient adherence, and treatment failure will also be addressed. Objectives Assess for risk factors of osteoporosis to identify which patients require additional screening Relate the application of available and emerging treatments for osteoporosis Faculty Bess Dawson Hughes, MD   Pain Management   Management of Patients with Refractory Chronic Low Back Pain in the Primary Care Setting Overview Patients with refractory chronic low back pain represent a clinical challenge to primary care practitioners. Worsening persistent pain, an array of comorbid conditions, and loss of function coupled with a lack of evidence for treatment can create a clinical conundrum. Learn how to improve the longitudinal management of patients presenting to your practice with this ubiquitous and demanding condition. Objectives Select validated tools for use in comprehensive assessment and risk-stratification of patients with refractory chronic low back pain treated with opioids Devise a treatment plan specific to the needs of chronic low back pain patients that demonstrate an understanding of recommended guidelines published jointly by the ACP/APS Faculty Steve P. Stanos, DO Bill McCarberg, MD Adjunct Assistant Clinical Professor University of California San Diego, CA   Rheumatoid Arthritis   The Triangle of Treatment: Taking a Team Approach to Managing Rheumatoid Arthritis Overview Rheumatoid arthritis (RA) is a complex immunologic and chronic inflammatory disease that affects more than 2 million people in the United States. Characterized by inflammation of the joints, periarticular bone resorption and cartilage destruction, RA is also an inherently aggressive, systemic disease that leaves patients vulnerable to comorbidities such as cardiovascular disease, osteoporosis, lymphoma, infection, and stroke. While primary care clinicians may not directly treat the disease long term, they are the first to come in contact with potential RA patients. Therefore it is important for all clinicians to be aware of the necessary steps in RA diagnostic and treatment modalities. Objectives Identify 3 early warning signs of rheumatoid arthritis (RA) Describe current and evolving treatment options for RA, and be alert to monitoring and side effects related to these therapies Faculty Yvonne R.S. Sherrer, MD Medical Director Director of Clinical Research Center for Rheumatology, Immunology, and Arthritis Ft. Lauderdale, FL Eric Ruderman, MD Associate Professor of Medicine Division of Rheumatology Northwestern University Feinberg School of Medicine Chicago, IL

Primary Care Network complies with the Americans with Disabilities Act. If you require special services to support your participation in this continuing education program, contact us directly
at 877-594-1770.

Overnight accommodations and parking fees are the responsibility of the participant of this CME activity. Please contact the hotel hosting this program to book overnight accommodations.